Gambia vs Niger: The number of people with susceptibility test result for rifampicin
Gambia
1,175
in 2021
Niger
1,127
in 2021
Gambia rank
62nd
Niger rank
63rd
The number of people with susceptibility test result for rifampicin over time
- Gambia
- Niger
How they compare
Gambia currently reports 1,175 against 1,127 in Niger, a difference of 48.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Niger ahead.
Gambia ranks 62nd and Niger ranks 63rd of 155 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gambia | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1 | 153 | 152 | Niger |
| 2020s | 646 | 965.5 | 319.5 | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Gambia or Niger?
- Gambia, at 1,175 against 1,127 in Niger as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Gambia and Niger?
- 48, with Gambia ahead.
- How many years of comparable data are there for Gambia and Niger?
- 5 years are reported by both, from 2017 to 2021.
- How do Gambia and Niger rank globally for the number of people with susceptibility test result for rifampicin?
- Gambia ranks 62nd and Niger ranks 63rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.